Interrater Agreement of BT-RADS for Evaluation of Follow-up MRI in Patients with Treated Primary Brain Tumor
American Journal of Neuroradiology · 2024
DOI: 10.3174/ajnr.a8322 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Neuroradiology, 2024. Verfasst von Michael Essien und 8 weiteren Autor:innen. Beteiligte Einrichtung: From the Department of Radiology and Imaging Sciences (M.E., M.E.C., A.G., T.L.M., R.H., B.D.W.). Hauptthemen laut MEDLINE: Brain Neoplasms, Magnetic Resonance Imaging, Observer Variation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: RSNA Research and Education Foundation.
Abstract (Originalsprache)
BACKGROUND AND PURPOSE: The Brain Tumor Reporting and Data System (BT-RADS) is a structured radiology reporting algorithm that was introduced to provide uniformity in posttreatment primary brain tumor follow-up and reporting, but its interrater reliability (IRR) assessment has not been widely studied. Our goal is to evaluate the IRR among neuroradiologists and radiology residents in the use of BT-RADS. MATERIALS AND METHODS: This retrospective study reviewed 103 consecutive MR studies in 98 adult patients previously diagnosed with and treated for primary brain tumor (January 2019 to February 2019). Six readers with varied experience (4 neuroradiologists and 2 radiology residents) independently evaluated each case and assigned a BT-RADS score. Readers were blinded to the original score reports and the reports from other readers. Cases in which at least 1 neuroradiologist scored differently were subjected to consensus scoring. After the study, a post hoc reference score was also assigned by 2 readers by using future imaging and clinical information previously unavailable to readers. The interrater reliabilities were assessed by using the Gwet AC2 index with ordinal weights and percent agreement. RESULTS: Of the 98 patients evaluated (median age, 53 years; interquartile range, 41-66 years), 53% were men. The most common tumor type was astrocytoma (77%) of which 56% were grade 4 glioblastoma. Gwet index for interrater reliability among all 6 readers was 0.83 (95% CI: 0.78-0.87). The Gwet index for the neuroradiologists' group (0.84 [95% CI: 0.79-0.89]) was not statistically different from that for the residents' group (0.79 [95% CI: 0.72-0.86]) (χ2 = 0.85; P = .36). All 4 neuroradiologists agreed on the same BT-RADS score in 57 of the 103 studies, 3 neuroradiologists agreed in 21 of the 103 studies, and 2 neuroradiologists agreed in 21 of the 103 studies. Percent agreement between neuroradiologist blinded scores and post hoc reference scores ranged from 41%-52%. CONCLUSIONS: A very good interrater agreement was found when tumor reports were interpreted by independent blinded readers by using BT-RADS criteria. Further study is needed to determine if this high overall agreement can translate into greater consistency in clinical care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- From the Department of Radiology and Imaging Sciences (M.E., M.E.C., A.G., T.L.M., R.H., B.D.W.).
- Rollins School of Public Health (B.B.R.), Emory University, Atlanta, Georgia.
- Department of Radiological Sciences (G.S.), University of California Irvine, Orange, California.
- From the Department of Radiology and Imaging Sciences (M.E., M.E.C., A.G., T.L.M., R.H., B.D.W.), Brent.d.weinberg@emory.edu.
ORCID-Profile: Michael Essien, Maxwell E Cooper, Ashwani Gore, Taejin L Min, Benjamin B Risk, Gelareh Sadigh, Ranliang Hu, Michael J Hoch, Brent D Weinberg
Förderung
- RSNA Research and Education Foundation
Zitieren
APA
Essien, M., Cooper, M. E., Gore, A., Min, T. L., Risk, B. B., Sadigh, G., Hu, R., Hoch, M. J., & Weinberg, B. D. (2024). Interrater Agreement of BT-RADS for Evaluation of Follow-up MRI in Patients with Treated Primary Brain Tumor. American Journal of Neuroradiology. https://doi.org/10.3174/ajnr.a8322
Vancouver
Essien M, Cooper ME, Gore A, Min TL, Risk BB, Sadigh G, et al. Interrater Agreement of BT-RADS for Evaluation of Follow-up MRI in Patients with Treated Primary Brain Tumor. American Journal of Neuroradiology. 2024. doi:10.3174/ajnr.a8322
BibTeX
@article{Essien2024,
author = {Essien, Michael and Cooper, Maxwell E and Gore, Ashwani and Min, Taejin L and Risk, Benjamin B and Sadigh, Gelareh and Hu, Ranliang and Hoch, Michael J and Weinberg, Brent D},
title = {Interrater Agreement of BT-RADS for Evaluation of Follow-up MRI in Patients with Treated Primary Brain Tumor},
journal = {American Journal of Neuroradiology},
year = {2024},
doi = {10.3174/ajnr.a8322}
}
EUVIMED